Click for best price

Rare Disease Genetic Testing Market Size, Share 2024

Report Overview

This report provides a deep insight into the global Rare Disease Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Rare Disease Genetic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Rare Disease Genetic Testing market in any manner.

Global Rare Disease Genetic Testing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Quest Diagnostics

Centogene

Invitae Corporation

3billion

Arup Laboratories

Eurofins Scientific

Strand Life Sciences

Ambry Genetics

Perkin Elmer

Macrogen

Baylor Genetics

Color Genomics

Preventiongenetics

Progenity

Coopersurgical

Fulgent Genetics

Myriad Genetics

LabCorp

Opko Health

Market Segmentation (by Type)

Next-Generation Sequencing (NGS)

Array Technology

PCR-based Testing

Fluorescence in Situ Hybridization (FISH)

Sanger Sequencing

Karyotyping

Others

Market Segmentation (by Application)

Research Laboratories and CROs

Diagnostic Laboratories

Hospitals and Clinics

Others

Geographic Segmentation

? North America (USA, Canada, Mexico)

? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

? South America (Brazil, Argentina, Columbia, Rest of South America)

? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

? Industry drivers, restraints, and opportunities covered in the study

? Neutral perspective on the market performance

? Recent industry trends and developments

? Competitive landscape & strategies of key players

? Potential & niche segments and regions exhibiting promising growth covered

? Historical, current, and projected market size, in terms of value

? In-depth analysis of the Rare Disease Genetic Testing Market

? Overview of the regional outlook of the Rare Disease Genetic Testing Market:

Key Reasons to Buy this Report:

? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

? This enables you to anticipate market changes to remain ahead of your competitors

? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

? Provision of market value (USD Billion) data for each segment and sub-segment

? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis

? Provides insight into the market through Value Chain

? Market dynamics scenario, along with growth opportunities of the market in the years to come

? 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rare Disease Genetic Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Report Attributes	Report Details
Report Title	Global Rare Disease Genetic Testing Market Research Report 2024(Status and Outlook)
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2023
Forecast Year	2031
Number of Pages	125 Pages
Customization Available	Yes, the report can be customized as per your need.

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Rare Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Rare Disease Genetic Testing Segment by Type
1.2.2 Rare Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Rare Disease Genetic Testing Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Rare Disease Genetic Testing Market Competitive Landscape
3.1 Global Rare Disease Genetic Testing Revenue Market Share by Company (2019-2024)
3.2 Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Rare Disease Genetic Testing Market Size Sites, Area Served, Product Type
3.4 Rare Disease Genetic Testing Market Competitive Situation and Trends
3.4.1 Rare Disease Genetic Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Rare Disease Genetic Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Rare Disease Genetic Testing Value Chain Analysis
4.1 Rare Disease Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Rare Disease Genetic Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Rare Disease Genetic Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2019-2024)
6.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2019-2024)
7 Rare Disease Genetic Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rare Disease Genetic Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Application (2019-2024)
8 Rare Disease Genetic Testing Market Segmentation by Region
8.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.2 Global Rare Disease Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Rare Disease Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rare Disease Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rare Disease Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rare Disease Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rare Disease Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Rare Disease Genetic Testing Basic Information
9.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Overview
9.1.3 Quest Diagnostics Rare Disease Genetic Testing Product Market Performance
9.1.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Centogene
9.2.1 Centogene Rare Disease Genetic Testing Basic Information
9.2.2 Centogene Rare Disease Genetic Testing Product Overview
9.2.3 Centogene Rare Disease Genetic Testing Product Market Performance
9.2.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.2.5 Centogene Business Overview
9.2.6 Centogene Recent Developments
9.3 Invitae Corporation
9.3.1 Invitae Corporation Rare Disease Genetic Testing Basic Information
9.3.2 Invitae Corporation Rare Disease Genetic Testing Product Overview
9.3.3 Invitae Corporation Rare Disease Genetic Testing Product Market Performance
9.3.4 Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
9.3.5 Invitae Corporation Business Overview
9.3.6 Invitae Corporation Recent Developments
9.4 3billion
9.4.1 3billion Rare Disease Genetic Testing Basic Information
9.4.2 3billion Rare Disease Genetic Testing Product Overview
9.4.3 3billion Rare Disease Genetic Testing Product Market Performance
9.4.4 3billion Business Overview
9.4.5 3billion Recent Developments
9.5 Arup Laboratories
9.5.1 Arup Laboratories Rare Disease Genetic Testing Basic Information
9.5.2 Arup Laboratories Rare Disease Genetic Testing Product Overview
9.5.3 Arup Laboratories Rare Disease Genetic Testing Product Market Performance
9.5.4 Arup Laboratories Business Overview
9.5.5 Arup Laboratories Recent Developments
9.6 Eurofins Scientific
9.6.1 Eurofins Scientific Rare Disease Genetic Testing Basic Information
9.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Overview
9.6.3 Eurofins Scientific Rare Disease Genetic Testing Product Market Performance
9.6.4 Eurofins Scientific Business Overview
9.6.5 Eurofins Scientific Recent Developments
9.7 Strand Life Sciences
9.7.1 Strand Life Sciences Rare Disease Genetic Testing Basic Information
9.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Overview
9.7.3 Strand Life Sciences Rare Disease Genetic Testing Product Market Performance
9.7.4 Strand Life Sciences Business Overview
9.7.5 Strand Life Sciences Recent Developments
9.8 Ambry Genetics
9.8.1 Ambry Genetics Rare Disease Genetic Testing Basic Information
9.8.2 Ambry Genetics Rare Disease Genetic Testing Product Overview
9.8.3 Ambry Genetics Rare Disease Genetic Testing Product Market Performance
9.8.4 Ambry Genetics Business Overview
9.8.5 Ambry Genetics Recent Developments
9.9 Perkin Elmer
9.9.1 Perkin Elmer Rare Disease Genetic Testing Basic Information
9.9.2 Perkin Elmer Rare Disease Genetic Testing Product Overview
9.9.3 Perkin Elmer Rare Disease Genetic Testing Product Market Performance
9.9.4 Perkin Elmer Business Overview
9.9.5 Perkin Elmer Recent Developments
9.10 Macrogen
9.10.1 Macrogen Rare Disease Genetic Testing Basic Information
9.10.2 Macrogen Rare Disease Genetic Testing Product Overview
9.10.3 Macrogen Rare Disease Genetic Testing Product Market Performance
9.10.4 Macrogen Business Overview
9.10.5 Macrogen Recent Developments
9.11 Baylor Genetics
9.11.1 Baylor Genetics Rare Disease Genetic Testing Basic Information
9.11.2 Baylor Genetics Rare Disease Genetic Testing Product Overview
9.11.3 Baylor Genetics Rare Disease Genetic Testing Product Market Performance
9.11.4 Baylor Genetics Business Overview
9.11.5 Baylor Genetics Recent Developments
9.12 Color Genomics
9.12.1 Color Genomics Rare Disease Genetic Testing Basic Information
9.12.2 Color Genomics Rare Disease Genetic Testing Product Overview
9.12.3 Color Genomics Rare Disease Genetic Testing Product Market Performance
9.12.4 Color Genomics Business Overview
9.12.5 Color Genomics Recent Developments
9.13 Preventiongenetics
9.13.1 Preventiongenetics Rare Disease Genetic Testing Basic Information
9.13.2 Preventiongenetics Rare Disease Genetic Testing Product Overview
9.13.3 Preventiongenetics Rare Disease Genetic Testing Product Market Performance
9.13.4 Preventiongenetics Business Overview
9.13.5 Preventiongenetics Recent Developments
9.14 Progenity
9.14.1 Progenity Rare Disease Genetic Testing Basic Information
9.14.2 Progenity Rare Disease Genetic Testing Product Overview
9.14.3 Progenity Rare Disease Genetic Testing Product Market Performance
9.14.4 Progenity Business Overview
9.14.5 Progenity Recent Developments
9.15 Coopersurgical
9.15.1 Coopersurgical Rare Disease Genetic Testing Basic Information
9.15.2 Coopersurgical Rare Disease Genetic Testing Product Overview
9.15.3 Coopersurgical Rare Disease Genetic Testing Product Market Performance
9.15.4 Coopersurgical Business Overview
9.15.5 Coopersurgical Recent Developments
9.16 Fulgent Genetics
9.16.1 Fulgent Genetics Rare Disease Genetic Testing Basic Information
9.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Overview
9.16.3 Fulgent Genetics Rare Disease Genetic Testing Product Market Performance
9.16.4 Fulgent Genetics Business Overview
9.16.5 Fulgent Genetics Recent Developments
9.17 Myriad Genetics
9.17.1 Myriad Genetics Rare Disease Genetic Testing Basic Information
9.17.2 Myriad Genetics Rare Disease Genetic Testing Product Overview
9.17.3 Myriad Genetics Rare Disease Genetic Testing Product Market Performance
9.17.4 Myriad Genetics Business Overview
9.17.5 Myriad Genetics Recent Developments
9.18 LabCorp
9.18.1 LabCorp Rare Disease Genetic Testing Basic Information
9.18.2 LabCorp Rare Disease Genetic Testing Product Overview
9.18.3 LabCorp Rare Disease Genetic Testing Product Market Performance
9.18.4 LabCorp Business Overview
9.18.5 LabCorp Recent Developments
9.19 Opko Health
9.19.1 Opko Health Rare Disease Genetic Testing Basic Information
9.19.2 Opko Health Rare Disease Genetic Testing Product Overview
9.19.3 Opko Health Rare Disease Genetic Testing Product Market Performance
9.19.4 Opko Health Business Overview
9.19.5 Opko Health Recent Developments
10 Rare Disease Genetic Testing Regional Market Forecast
10.1 Global Rare Disease Genetic Testing Market Size Forecast
10.2 Global Rare Disease Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rare Disease Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region
10.2.4 South America Rare Disease Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rare Disease Genetic Testing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Rare Disease Genetic Testing Market Forecast by Type (2025-2030)
11.2 Global Rare Disease Genetic Testing Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rare Disease Genetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Rare Disease Genetic Testing Revenue (M USD) by Company (2019-2024)
Table 6. Global Rare Disease Genetic Testing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2022)
Table 8. Company Rare Disease Genetic Testing Market Size Sites and Area Served
Table 9. Company Rare Disease Genetic Testing Product Type
Table 10. Global Rare Disease Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Rare Disease Genetic Testing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Rare Disease Genetic Testing Market Challenges
Table 18. Global Rare Disease Genetic Testing Market Size by Type (M USD)
Table 19. Global Rare Disease Genetic Testing Market Size (M USD) by Type (2019-2024)
Table 20. Global Rare Disease Genetic Testing Market Size Share by Type (2019-2024)
Table 21. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Rare Disease Genetic Testing Market Size by Application
Table 23. Global Rare Disease Genetic Testing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Rare Disease Genetic Testing Market Share by Application (2019-2024)
Table 25. Global Rare Disease Genetic Testing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Rare Disease Genetic Testing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Rare Disease Genetic Testing Market Size Market Share by Region (2019-2024)
Table 28. North America Rare Disease Genetic Testing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Rare Disease Genetic Testing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Rare Disease Genetic Testing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Rare Disease Genetic Testing Market Size by Region (2019-2024) & (M USD)
Table 33. Quest Diagnostics Rare Disease Genetic Testing Basic Information
Table 34. Quest Diagnostics Rare Disease Genetic Testing Product Overview
Table 35. Quest Diagnostics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
Table 37. Quest Diagnostics Business Overview
Table 38. Quest Diagnostics Recent Developments
Table 39. Centogene Rare Disease Genetic Testing Basic Information
Table 40. Centogene Rare Disease Genetic Testing Product Overview
Table 41. Centogene Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
Table 43. Centogene Business Overview
Table 44. Centogene Recent Developments
Table 45. Invitae Corporation Rare Disease Genetic Testing Basic Information
Table 46. Invitae Corporation Rare Disease Genetic Testing Product Overview
Table 47. Invitae Corporation Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Quest Diagnostics Rare Disease Genetic Testing SWOT Analysis
Table 49. Invitae Corporation Business Overview
Table 50. Invitae Corporation Recent Developments
Table 51. 3billion Rare Disease Genetic Testing Basic Information
Table 52. 3billion Rare Disease Genetic Testing Product Overview
Table 53. 3billion Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. 3billion Business Overview
Table 55. 3billion Recent Developments
Table 56. Arup Laboratories Rare Disease Genetic Testing Basic Information
Table 57. Arup Laboratories Rare Disease Genetic Testing Product Overview
Table 58. Arup Laboratories Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Arup Laboratories Business Overview
Table 60. Arup Laboratories Recent Developments
Table 61. Eurofins Scientific Rare Disease Genetic Testing Basic Information
Table 62. Eurofins Scientific Rare Disease Genetic Testing Product Overview
Table 63. Eurofins Scientific Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Recent Developments
Table 66. Strand Life Sciences Rare Disease Genetic Testing Basic Information
Table 67. Strand Life Sciences Rare Disease Genetic Testing Product Overview
Table 68. Strand Life Sciences Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Strand Life Sciences Business Overview
Table 70. Strand Life Sciences Recent Developments
Table 71. Ambry Genetics Rare Disease Genetic Testing Basic Information
Table 72. Ambry Genetics Rare Disease Genetic Testing Product Overview
Table 73. Ambry Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Ambry Genetics Business Overview
Table 75. Ambry Genetics Recent Developments
Table 76. Perkin Elmer Rare Disease Genetic Testing Basic Information
Table 77. Perkin Elmer Rare Disease Genetic Testing Product Overview
Table 78. Perkin Elmer Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Perkin Elmer Business Overview
Table 80. Perkin Elmer Recent Developments
Table 81. Macrogen Rare Disease Genetic Testing Basic Information
Table 82. Macrogen Rare Disease Genetic Testing Product Overview
Table 83. Macrogen Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Macrogen Business Overview
Table 85. Macrogen Recent Developments
Table 86. Baylor Genetics Rare Disease Genetic Testing Basic Information
Table 87. Baylor Genetics Rare Disease Genetic Testing Product Overview
Table 88. Baylor Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Baylor Genetics Business Overview
Table 90. Baylor Genetics Recent Developments
Table 91. Color Genomics Rare Disease Genetic Testing Basic Information
Table 92. Color Genomics Rare Disease Genetic Testing Product Overview
Table 93. Color Genomics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Color Genomics Business Overview
Table 95. Color Genomics Recent Developments
Table 96. Preventiongenetics Rare Disease Genetic Testing Basic Information
Table 97. Preventiongenetics Rare Disease Genetic Testing Product Overview
Table 98. Preventiongenetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Preventiongenetics Business Overview
Table 100. Preventiongenetics Recent Developments
Table 101. Progenity Rare Disease Genetic Testing Basic Information
Table 102. Progenity Rare Disease Genetic Testing Product Overview
Table 103. Progenity Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Progenity Business Overview
Table 105. Progenity Recent Developments
Table 106. Coopersurgical Rare Disease Genetic Testing Basic Information
Table 107. Coopersurgical Rare Disease Genetic Testing Product Overview
Table 108. Coopersurgical Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Coopersurgical Business Overview
Table 110. Coopersurgical Recent Developments
Table 111. Fulgent Genetics Rare Disease Genetic Testing Basic Information
Table 112. Fulgent Genetics Rare Disease Genetic Testing Product Overview
Table 113. Fulgent Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Fulgent Genetics Business Overview
Table 115. Fulgent Genetics Recent Developments
Table 116. Myriad Genetics Rare Disease Genetic Testing Basic Information
Table 117. Myriad Genetics Rare Disease Genetic Testing Product Overview
Table 118. Myriad Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Myriad Genetics Business Overview
Table 120. Myriad Genetics Recent Developments
Table 121. LabCorp Rare Disease Genetic Testing Basic Information
Table 122. LabCorp Rare Disease Genetic Testing Product Overview
Table 123. LabCorp Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 124. LabCorp Business Overview
Table 125. LabCorp Recent Developments
Table 126. Opko Health Rare Disease Genetic Testing Basic Information
Table 127. Opko Health Rare Disease Genetic Testing Product Overview
Table 128. Opko Health Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Opko Health Business Overview
Table 130. Opko Health Recent Developments
Table 131. Global Rare Disease Genetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 132. North America Rare Disease Genetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Europe Rare Disease Genetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 134. Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 135. South America Rare Disease Genetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Rare Disease Genetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Global Rare Disease Genetic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 138. Global Rare Disease Genetic Testing Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Industrial Chain of Rare Disease Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rare Disease Genetic Testing Market Size (M USD), 2019-2030
Figure 5. Global Rare Disease Genetic Testing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Rare Disease Genetic Testing Market Size by Country (M USD)
Figure 10. Global Rare Disease Genetic Testing Revenue Share by Company in 2023
Figure 11. Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Rare Disease Genetic Testing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Rare Disease Genetic Testing Market Share by Type
Figure 15. Market Size Share of Rare Disease Genetic Testing by Type (2019-2024)
Figure 16. Market Size Market Share of Rare Disease Genetic Testing by Type in 2022
Figure 17. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Rare Disease Genetic Testing Market Share by Application
Figure 20. Global Rare Disease Genetic Testing Market Share by Application (2019-2024)
Figure 21. Global Rare Disease Genetic Testing Market Share by Application in 2022
Figure 22. Global Rare Disease Genetic Testing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Rare Disease Genetic Testing Market Size Market Share by Region (2019-2024)
Figure 24. North America Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Rare Disease Genetic Testing Market Size Market Share by Country in 2023
Figure 26. U.S. Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Rare Disease Genetic Testing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Rare Disease Genetic Testing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Rare Disease Genetic Testing Market Size Market Share by Country in 2023
Figure 31. Germany Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Region in 2023
Figure 38. China Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 44. South America Rare Disease Genetic Testing Market Size Market Share by Country in 2023
Figure 45. Brazil Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Rare Disease Genetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Rare Disease Genetic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Rare Disease Genetic Testing Market Share Forecast by Type (2025-2030)
Figure 57. Global Rare Disease Genetic Testing Market Share Forecast by Application (2025-2030)

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $3095

Multi User Price : $4048

Enterprise Price : $5000

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Rare Disease Genetic Testing Market Research Report 2024(Status and Outlook)